Literature DB >> 8093259

Subtypes of sodium-dependent high-affinity L-[3H]glutamate transport activity: pharmacologic specificity and regulation by sodium and potassium.

M B Robinson1, J D Sinor, L A Dowd, J F Kerwin.   

Abstract

Some data suggest that the sodium-dependent, high-affinity L-glutamate (Glu) transport sites in forebrain are different from those in cerebellum. In the present study, sodium-dependent transport of L-[3H]Glu was characterized in cerebellum and cortex. In both cerebellar and cortical tissue, activity was enriched in synaptosomes. Approximately 100 excitatory amino acid analogues were tested as potential inhibitors of transport activity. Many of the compounds tested inhibited transport activity by < 65% at 1 mM and were not studied further. One group of compounds exhibited inhibition conforming to theoretical curves with Hill coefficients of 1 and were < 10-fold selective as inhibitors of transport activity. These included three of the putative endogenous substrates for transport: L-Glu, L-aspartate, and L-cysteate. Four of the compounds exhibited inhibition conforming to theoretical curves with Hill coefficients of 1 and were > 10-fold selective as inhibitors. These included beta-N-oxalyl-L-alpha,beta-diaminopropionate, alpha-methyl-DL-glutamate, (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine, and (2S,1'S,2'S,3'S)-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine. Data obtained with a few of the inhibitors were consistent with two sites in one or both of the brain regions. (2S,1'R,2'R)-2-(Carboxycyclopropyl)glycine (L-CCG-II) was identified as the most potent (IC50 = 5.5 microM) and selective (60-100-fold) inhibitor of transport activity in cerebellum. One of the potential endogenous substrates, L-homocysteate, was also a selective inhibitor of cerebellar transport activity. The data for inhibition of transport activity in cortex by both L-CCG-II and L-homocysteate were best fit to two sites. Kainate was equipotent as an inhibitor of transport activity, and in both brain regions the data for inhibition were best fit to two sites. The possibility that there are four subtypes of excitatory amino acid transport is discussed. Altering sodium and potassium levels affects cerebellar and cortical transport activity differently, suggesting that the differences extend to other recognition sites on these transporters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093259     DOI: 10.1111/j.1471-4159.1993.tb05835.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons.

Authors:  Weizhi Chen; Veeravan Mahadomrongkul; Urs V Berger; Merav Bassan; Tara DeSilva; Kohichi Tanaka; Nina Irwin; Chiye Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

2.  Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.

Authors:  Geraldine T Petr; Yan Sun; Natalie M Frederick; Yun Zhou; Sameer C Dhamne; Mustafa Q Hameed; Clive Miranda; Edward A Bedoya; Kathryn D Fischer; Wencke Armsen; Jianlin Wang; Niels C Danbolt; Alexander Rotenberg; Chiye J Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

3.  Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity.

Authors:  Ross D O'Shea; Melissa V Fodera; Karina Apricó; Yvette Dehnes; Niels C Danbolt; Duncan Crawford; Philip M Beart
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

4.  Effects of L-glutamate transport inhibition by a conformationally restricted glutamate analogue (2S,1'S,2'R)-2-(carboxycyclopropyl)glycine (L-CCG III) on metabolism in brain tissue in vitro analysed by NMR spectroscopy.

Authors:  Charbel El-Hajj Moussa; Ann D Mitrovic; Robert J Vandenberg; Tanya Provis; Caroline Rae; William A Bubb; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

5.  Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L-glutamate transporter.

Authors:  J Dunlop; Z Lou; Y Zhang; H B McIlvain
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Evidence for change in current-flux coupling of GLT1 at high glutamate concentrations in rat primary forebrain neurons and GLT1a-expressing COS-7 cells.

Authors:  Anatoli Y Kabakov; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2009-07-09       Impact factor: 3.386

7.  Differences in the release of L-glutamate and D-aspartate from primary neuronal chick cultures.

Authors:  L Lewin; M O Mattsson; A Sellström
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

Review 8.  GLT-1: The elusive presynaptic glutamate transporter.

Authors:  Theresa S Rimmele; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2016-04-26       Impact factor: 3.921

9.  The Na(+)-dependent binding of [3H]L-aspartate in thaw-mounted sections of rat forebrain.

Authors:  Y Li; V J Balcar
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

10.  Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus.

Authors:  D E Pellegrini-Giampietro; S A Torregrossa; F Moroni
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.